Immortal tumor cells employ a telomere length maintenance mechanism to escape the normal limits on proliferation. We investigated whether treatment with cytosine arabinoside (AraC), whose triphosphate derivative AraCTP might partially inhibit the synthesis of C-rich telomere strands, is effective for inducing telomere shortening in human HL60 cells. Long-term treatment with 0.01 microM AraC was found to cause significant telomere lengthening, but had no marked effects on cell population doubling rates or morphology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/nass/49.1.289 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!